Form 8-K - Current report:
SEC Accession No. 0001698530-25-000030
Filing Date
2025-04-14
Accepted
2025-04-14 16:28:20
Documents
14
Period of Report
2025-04-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20250414.htm   iXBRL 8-K 29088
2 EX-16.1 exhibit161.htm EX-16.1 2698
  Complete submission text file 0001698530-25-000030.txt   156263

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250414.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250414_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250414_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250414_htm.xml XML 2724
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 25836348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)